Understanding Immunotherapy – A New Approach to Cancer Treatment

The Basics of Immune Response

Our immune system constantly patrols our bodies, identifying and eliminating foreign invaders like bacteria and viruses. When cancer develops, it can evade this normal response. Immunotherapy aims to reactivate or enhance the immune system’s ability to recognize and destroy cancerous cells.

Types of Immunotherapy

Several distinct approaches fall under immunotherapy's umbrella. These include: *Checkpoint Inhibitors*, which block signals that prevent the immune system from attacking cancer cells; *CAR T-cell Therapy*, where a patient’s own immune cells are genetically modified to recognize and kill cancer cells; and *Cancer Vaccines*, designed to stimulate an immune response against specific tumor antigens.

T cell activation requires co-stimulatory signals, often mediated by CD80/CD86 interaction with the T cell receptor.

How Checkpoint Inhibitors Work

Many cancer cells express proteins called PD-L1 that bind to receptors on immune cells (T cells), effectively ‘switching off’ their ability to attack. Checkpoint inhibitors block this interaction, allowing T cells to recognize and destroy cancer cells. This is akin to removing a brake from the immune system.

PD-L1 + PD-1 = Immune Suppression

Limitations & Future Directions

Immunotherapy isn’t effective for all cancers and can cause side effects, including autoimmune reactions. Research is ongoing to improve its efficacy and minimize these risks. Combinations of immunotherapy with other treatments are also being explored to enhance the overall response.

Frequently asked questions

Try it live

Everything above runs in your browser — open Michaelis-Menten Kinetics and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.